Skip to main content

Complications

Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.

Last month, in early September, results from the DPP-4 inhibitor cardiovascular outcomes trials SAVOR-TIMI 53 (for Bristol Myers Squibb and AstraZeneca’s Onglyza) and...
All about diabetic macular edema (DME) and three tips for avoiding it.
Last month, the Fight4MyFeet campaign launched to increase awareness of diabetic foot ulcers among people with diabetes, including a host of valuable tips on how to...
All you need to know about diabetic neuropathy - the facts, prevention, and treatment.
In a whirlwind of diabetes news, a glimmer of hope for reducing diabetes complications.
On March 18, NeuroMetrix launched the second-generation version of its Sensus pain management device, The Sensus is designed to relieve the pain and numbness often...
At the end of March, encouraging news about Takeda’s once-daily pill for type 2 diabetes, Nesina (alogliptin), circulated at the American College of Cardiology (ACC)...
In February, Johnson and Johnson announced that its SGLT-2 inhibitor for type 2 diabetes, Invokana (canagliflozin), will undergo trials as a treatment for diabetic...
Update (1/12/15): Medtronic Diabetes gave an update on their upcoming diabetes device pipeline at the J.P. Morgan Healthcare Conference. The MiniMed 640G is expected to...
On June 11, Glooko and the Joslin Diabetes Center announced the release of their HypoMap software , a cool product that really should be able to identify and help...
The curious milestone of a diabetes anniversary.
Our overview of what all of us need to know about one of our most vital organs – our kidneys.
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
How these two FDA-submitted drugs could address this major healthcare need.
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
Our deep dive on a new therapy now available in Europe – the benefits, risks, and when it might come to the US.
How this new option makes it easier to diagnose this major diabetes complication.
How a major research study is challenging an outdated FDA restriction.
Why these two seemingly different diseases may be more similar than you think.

Pages